Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8504161 Modulate vagal signals to reduce inflammation

Patent 8504161 was granted and assigned to Medtronic on August, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Medtronic

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8504161

Date of Patent

August 6, 2013

Patent Application Number

13568281

Date Filed

August 7, 2012

Patent Citations Received

‌

US Patent 12121726 Control of vagal stimulation

‌

US Patent 11944810 Systems and methods for trans-esophageal sympathetic ganglion recruitment

‌

US Patent 11964150 Batteryless implantable microstimulators

‌

US Patent 11969253 Closed-loop vagus nerve stimulation

‌

US Patent 11707619 Apparatus and methods for assisted breathing by transvascular nerve stimulation

‌

US Patent 11771900 Circuitry for medical stimulation systems

‌

US Patent 11857788 Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation

‌

US Patent 11883658 Devices and methods for prevention, moderation, and/or treatment of cognitive injury

...

Patent Primary Examiner

‌

Niketa Patel

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8504161 Modulate vagal signals to reduce inflammation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API